CN104800370A - 治疗猪蓝耳病的中草药注射液 - Google Patents
治疗猪蓝耳病的中草药注射液 Download PDFInfo
- Publication number
- CN104800370A CN104800370A CN201510200575.2A CN201510200575A CN104800370A CN 104800370 A CN104800370 A CN 104800370A CN 201510200575 A CN201510200575 A CN 201510200575A CN 104800370 A CN104800370 A CN 104800370A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese herbal
- herbal medicine
- injection
- blue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 33
- 239000007924 injection Substances 0.000 title claims abstract description 33
- 208000032625 disorder of ear Diseases 0.000 title claims abstract description 16
- 235000014134 echinacea Nutrition 0.000 claims abstract description 20
- 240000000011 Artemisia annua Species 0.000 claims abstract description 18
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 15
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 14
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 241001061264 Astragalus Species 0.000 claims abstract description 10
- 244000133098 Echinacea angustifolia Species 0.000 claims abstract description 10
- 210000004233 talus Anatomy 0.000 claims abstract description 10
- 241000092665 Atractylodes macrocephala Species 0.000 claims abstract description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 3
- 241000411851 herbal medicine Species 0.000 claims description 41
- 239000003814 drug Substances 0.000 claims description 23
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 16
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 16
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 16
- 229940010454 licorice Drugs 0.000 claims description 16
- 241000202807 Glycyrrhiza Species 0.000 claims description 14
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 5
- 241000594394 Hedyotis Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 238000010411 cooking Methods 0.000 abstract description 3
- 239000000706 filtrate Substances 0.000 abstract description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract description 3
- 229920000053 polysorbate 80 Polymers 0.000 abstract description 3
- 238000004090 dissolution Methods 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 229940088679 drug related substance Drugs 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 238000004042 decolorization Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 23
- 229940079593 drug Drugs 0.000 description 14
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 240000004530 Echinacea purpurea Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 8
- 210000002540 macrophage Anatomy 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000000242 pagocytic effect Effects 0.000 description 7
- 239000008215 water for injection Substances 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000000120 cytopathologic effect Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000132012 Atractylodes Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 102000014150 Interferons Human genes 0.000 description 5
- 108010050904 Interferons Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 229940079322 interferon Drugs 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- -1 orogenin A Natural products 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000003322 Coinfection Diseases 0.000 description 3
- 208000035240 Disease Resistance Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 241000606750 Actinobacillus Species 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000606807 Glaesserella parasuis Species 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 240000008436 Ipomoea aquatica Species 0.000 description 2
- 235000019004 Ipomoea aquatica Nutrition 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241000606856 Pasteurella multocida Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 2
- 229940015301 baicalein Drugs 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 230000005965 immune activity Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 229940051027 pasteurella multocida Drugs 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 2
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- RCFODGQQTAADES-UHFFFAOYSA-N 3beta-acetoxy-atractylone Natural products CC(=O)OC1C2C(=C)CCCC2(C)Cc3occ(C)c13 RCFODGQQTAADES-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241001597062 Channa argus Species 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- MKZIRHIVARSBHI-UHFFFAOYSA-N Clovene Natural products C1CCC2(C)CCC3C(C)(C)C=CC31C2 MKZIRHIVARSBHI-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GUSFNHMDMCPUPO-DYLBMRNYSA-N [(3as,4r,6as,7r,10s,10ar)-4,7-dimethyl-8-oxo-3,3a,4,5,6,6a,7,10-octahydro-2h-furo[3,2-i]isochromen-10-yl] acetate Chemical compound C[C@H]([C@@H]1CC[C@H]2C)C(=O)O[C@H](OC(C)=O)[C@@]11[C@H]2CCO1 GUSFNHMDMCPUPO-DYLBMRNYSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- SOSLMHZOJATCCP-AEIZVZFYSA-N afzelin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O SOSLMHZOJATCCP-AEIZVZFYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- GJYJYFHBOBUTBY-UHFFFAOYSA-N alpha-camphorene Chemical compound CC(C)=CCCC(=C)C1CCC(CCC=C(C)C)=CC1 GJYJYFHBOBUTBY-UHFFFAOYSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- HAVYZKHVTLAPDZ-RCHZWEEESA-N beta-Humulene Natural products C\C1=C\CC(C)(C)\C=C\CC(=C)CCC1 HAVYZKHVTLAPDZ-RCHZWEEESA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229960002727 cefotaxime sodium Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000001985 kidney epithelial cell Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- ZTHLHHDJRXJGRX-UHFFFAOYSA-N neglectein Natural products C=1C(=O)C=2C(O)=C(O)C(OC)=CC=2OC=1C1=CC=CC=C1 ZTHLHHDJRXJGRX-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000012153 swine disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- HAVYZKHVTLAPDZ-PRUKLFJYSA-N β-humulene Chemical compound C\C1=C\CC(C)(C)\C=C/CC(=C)CCC1 HAVYZKHVTLAPDZ-PRUKLFJYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗猪蓝耳病的中草药注射液,该中草药注射液由下述重量份的原料药制成:青蒿1-2份,黄芩2-4份,鱼腥草4-6份,白花蛇舌草4-6份,紫锥菊4-6份,黄芪4-6份,白术2-4份,甘草1-2份。上述原料经过粉碎,配料,三次水煮浸提,合并三次滤液,浓缩后醇沉,调pH,活性炭脱色,吐温-80助溶,按定量加入防腐剂,搅匀,过滤,灌装,灭菌,制成本发明治疗猪蓝耳病的中草药注射液。本发明中草药注射液对治疗猪蓝耳病有很好的效果。
Description
技术领域
本发明涉及治疗猪病用的中草药制剂,具体涉及一种治疗猪蓝耳病的中草药注射液。
背景技术
猪蓝耳病即猪繁殖与呼吸综合征(PRRS),是由猪繁殖与呼吸综合征病毒(PRRSV)引起的猪的一种高度接触性传染病,不同年龄、品种和性别的猪均能感染,但以妊娠母猪和1月龄以内的仔猪最易感染。该病以母猪流产、死胎、弱胎、木乃伊胎以及仔猪呼吸困难、败血症、高死亡率等为主要特征。因发病时部分病猪的特征表现是耳部发紫,故该病又称为“猪蓝耳病”。近年来普遍流行的高致病性猪蓝耳病,是由PRRSV变异株引起的一种急性高致死性传染病,仔猪发病率可达100%、死亡率可达50%以上,母猪流产率可达30%以上,育肥猪也可发病及死亡;PRRSV感染后,首先在局部的易感巨噬细胞中复制,然后迅速向全身淋巴组织和肺扩散,有时也向其他组织扩散。病毒在细胞内增殖,使巨噬细胞破裂,溶解崩溃造成巨噬细胞数量减少,肺泡壁增厚,淋巴组织呈衰竭状态,肺泡巨噬细胞对其他细菌和病毒疫苗的免疫力降低,易继发感染猪瘟病毒(CSFV)、多杀性巴氏杆菌(PM)、链球菌(SS)、猪副嗜血杆菌(HP)、放线杆菌(AS)、支原体(MHR)、圆环病毒(PCV-2)等,这是本病与其他疾病混合或继发感染的根本原因。同时因为毒株的变异导致免疫细胞识别能力降低,而逃避抗体的中和及细胞毒性T细胞的杀伤作用。因此,有效的防治猪蓝耳病的治则是:清热解毒,抗菌消炎,激活免疫系统,恢复巨噬细胞功能,抑制病毒繁殖,促进巨噬细胞摄取、处理和传递抗原,调节和增强T/B细胞的反应能力、增加T/B细胞的数量及促进其发育成熟,使猪在接种疫苗后能获得高水平的免疫应答反应。目前,化学药物增强机体免疫力都不同程度地存在着毒副作用、药物残留和阶段性用药达不到理想效果的弊端。中草药属于天然、绿色药物,对动物及人类安全、无毒副作用,并且能从根本上调节机体免疫功能。目前中草药制剂的研究有了较大发展,治疗猪病的兽用中草药种类也较多,但能够有效治疗猪蓝耳病的中草药注射液尚未见有报道。
发明内容
本发明的目的在于针对上述问题,提供一种能够有效治疗猪蓝耳病的中草药注射液。
本发明的技术方案是:一种治疗猪蓝耳病的中草药注射液,它由下述重量份的原料药制成:青蒿1-2份,黄芩2-4份,鱼腥草4-6份,白花蛇舌草4-6份,紫锥菊4-6份,黄芪4-6份,白术2-4份,甘草1-2份。
本发明治疗猪蓝耳病的中草药注射液优选的原料药重量份是:青蒿2份,黄芩4份,鱼腥草4份,白花蛇舌草4份,紫锥菊4份,黄芪4份,白术2份,甘草1份。
本发明治疗猪蓝耳病的中草药注射液的制备方法包括以下步骤:
(1)按重量份配比分别称取青蒿、黄芩、鱼腥草、白花蛇舌草、紫锥菊、黄芪、白术、甘草中草药饮片,并分别粉碎成中草药粗粉;
(2)取黄芩、黄芪、白术、甘草中草药粗粉,按步骤(1)得到的中草药粗粉总重量的7倍加注射水浸泡20-30min,加热煎煮25-35min,再加入青蒿、鱼腥草、白花蛇舌草、紫锥菊中草药粗粉煎煮25-35min,倾出第一次煮液,再按步骤(1)得到的中草药粗粉总重量的5倍分别加注射水两次煎煮,每次煎煮25-35min,得到第二次煮液和第三次煮液;
(3)合并步骤(2)得到的三次煮液,过滤,浓缩至每毫升注射水含生药1g,得到浓缩煮液;
(4)将步骤(3)得到的浓缩煮液加入3倍重量的浓度为95%的乙醇,边加入边搅拌,静置24h,除去沉淀并回收乙醇,浓缩至每毫升注射水含生药2g,得到浓缩药液;
(5)滴加稀氢氧化钠使步骤(4)得到的浓缩药液的pH达到7.0,按所述浓缩药液重量的0.15%加入活性炭,煮沸25-30min,放置12h,再按所述浓缩药液重量的1%各加入苯甲醇和吐温-80,搅匀,G-3号垂熔玻璃漏斗过滤,滤液用注射水补足至每毫升注射水含生药2g,灌装,灭菌,即得本治疗猪蓝耳病的中草药注射液。
本发明组方中各组份药理功效是:
1.青蒿功效:青蒿别名草蒿、茵陈蒿、邪蒿,香蒿等。性寒、味苦辛,归肝、胆、三焦、肾经。全草含倍半萜类如青蒿素、青蒿素G等,亦含挥发性成分如莰烯、β-莰烯、异蒿酮等,尚含黄酮类成分如山柰黄素、槲皮黄素、黄色黄素,还含香豆素、6-甲氧基-7-羟基香豆素等。青蒿水煎液对表皮葡萄球菌、卡他球菌、炭疽杆菌、白喉杆菌有较强的抑菌作用,对金黄色葡萄球菌、绿脓杆菌、痢疾杆菌、结核秆菌等也有一定的抑制作用。具有清热退蒸,清暑截疟之功效,用于阴虚潮热、黄疸、泻痢等。
2.黄芩功效:黄芩别名山茶根、黄芩茶、土金茶根等。味苦,寒。归肺、胆、脾、大肠、小肠经。黄芩根含黄酮类化合物:黄芩素,黄芩新素,黄芩甙,汉黄芩素,汉黄芩甙,木蝴蝶素A,7-甲氧基黄芩素,二氢木蝴蝶素,白杨素,另外还含β-谷甾醇,菜油甾醇及豆甾醇等有效成分。对痢疾杆菌、大肠杆菌、变形杆菌、绿脓杆菌、葡萄球菌、溶血性琏球菌等有抑制作用。有清热燥湿,凉血解毒之功效。主治温热病、上呼吸道感染、肺热咳嗽、肺炎等症。
3.鱼腥草功效:鱼腥草别名岑草、蕺菜、菹菜、紫背鱼腥草。性微寒、味苦。归肺、肝、膀胱、大肠经。含挥发油,内含抗菌有效成分癸酰乙醛,月桂醛,a-蒎烯和芳樟醇,甲基正壬基甲酮,樟烯,月桂烯,柠檬烯,乙酸龙脑酯,丁香烯,阿福甙,金丝桃甙,芸香甙。具有清热解毒之功效。用于肺炎、肺脓疡,热痢等。
4.白花蛇舌草功效:白花蛇舌草别名蛇舌草、羊须草、蛇总管等。味微苦,性寒。归胃、大肠、小肠经。含三十一烷、豆固醇、乌索酸、齐墩果酸、黄酮甙及百合蛇舌草素等。具清热解毒,利湿通淋之功效。用于肺热喘咳、咽喉肿痛、肠痈、疖肿疮疡、热淋涩痛、水肿、痢疾、肠炎、湿热黄疸等症。
5.紫锥菊功效:紫锥菊别名紫锥花、紫松果菊、紫花松果菊。性微寒,味辛、苦,归肺、肝经。含有多糖、黄酮、咖啡酸的衍生物、精油、多炔、烷基胺和生物碱。有免疫刺激作用,减少发炎,帮助机体对抗细菌和病毒。用紫锥菊饲喂动物,可提高嗜中性粒细胞的吞噬能力及外周淋巴细胞的数量,有效刺激动物机体的免疫活性;将紫锥菊根制成饲料添加剂喂鸡,可明显增加实验组体重和降低球虫的感染率。
6.黄芪功效:黄芪别称棉芪,黄耆,独椹,蜀脂,百本。味甘,微温。归肺,脾,肝,肾经。含皂甙、黄酮、多糖、多种氨基酸、叶酸及硒、锌、铜等多种微量元素,具有增强机体免疫功能、保肝、利尿、降压、抗衰老、抗缺氧、抗辐射、抗应激、耐低温和耐高温作用。动物试验证明,能够增加网状内皮系统的吞噬功能,促进抗体形成,提高E-玫瑰花环率,促进T细胞的分化与成熟,增强NK细胞的细胞毒活性,诱导产生干扰素,对动物流感病毒、腺病毒等所致的细胞病变有抑制作用。有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。用于治疗气虚乏力,中气下陷,表虚自汗,痈疽难溃,久溃不敛,血虚萎黄,内热消渴等症。
7.白术功效:白术别名于术、冬术、冬白术、浙术、云术、台白术、山蓟、天蓟、杭白术等。性味苦甘、温、无毒。归脾、胃经。根茎含挥发油,内有α-及β-葎草烯,β-榄香醇,苍术酮,3β-乙酰氧基苍术酮,芹子二烯酮等。还含倍半萜内酯化合物:苍术内酯-Ⅰ、-Ⅱ、-Ⅲ及8β-乙氧基苍术内酯-Ⅱ。又含多炔类化合物。另含东莨菪素,果糖,具免疫活性的甘露聚糖AM-3,以及天冬氨酸等氨基酸。白术能增强网状内皮系统的吞噬功能,对小鼠网状内皮系统呈活化作用,促进小鼠腹腔巨噬细胞的吞噬功能,使巨噬细胞的吞噬百分率,吞噬指数及其溶酶体消化平均较对照组显著增加。具补脾益胃,燥湿和中之功效。用于脾胃气弱,不思饮食。
8.甘草功效:甘草别名甜草根、红甘草、粉甘草。性平,味甘,归十二经。甘草主要含甘草酸、甘草甜素、24-羟基甘草次酸、甘草黄酮、甘草素、异甘草素、甘草多糖等成分,具有抗溃疡、促进胰腺分泌、保肝、降脂、调节巨噬细胞的吞噬功能等作用。甘草酸是天然解毒剂,可用于机体抗衰老、增强免疫力、维持水盐代谢平衡等。
本发明组方依据:本组方以扶正祛邪,增强猪抗病、防病能力,提高免疫力为原则。方中青蒿、黄芩为清热、解毒主药;黄芩、鱼腥草、白花蛇舌草为清热、解毒、抗菌、消炎辅药,紫锥菊具有免疫刺激作用,减少发炎,而且可帮助机体对抗细菌和病毒;黄芪、白术有补中益气,生津养血,扶正祛邪,调节机体免疫功能;甘草甘温益气、和中健脾,通行十二经络,调和诸药。方中诸药相和,共奏清热解毒,抗菌消炎,提高机体免疫力和抗病能力的功效。为增强治疗效果,制成注射液。
本发明中草药注射液适用于由猪蓝耳病病毒及其因猪蓝耳病病毒感染引起的各种细菌的继发感染。
本发明中草药注射液具有清热解毒、抗菌消炎功效,能增强猪抗病、防病能力,提高免疫力,作为治疗猪蓝耳病的中草药制剂,具有良好的效果。
具体实施方式
下面结合实施例对本发明作进一步说明。
实施例:
1、分别称取原料药(饮片):青蒿100g,黄芩200g,鱼腥草200g,白花蛇舌草200g,紫锥菊200g,黄芪200g,白术100g,甘草50g。
2、将上述原料药分别粉碎成中草药粗粉;
3、将黄芩、黄芪、白术、甘草四味中草药粗粉混合,加水7000mL浸泡1h后,文火煎煮30min,再放入青蒿、鱼腥草、白花蛇舌草、紫锥菊中草药粗粉,文火煎煮30min,得到第一次煮液,然后再每次加水5000mL煎煮二次,每次煎煮30min,得到第二次煮液和第三次煮液;
4、合并上述三次煮液,过滤,浓缩至每毫升注射水含生药1g,得到浓缩煮液,然后加入浓度为95%的乙醇1500mL,边加入边搅拌,静置24h,去沉淀取上清液,蒸去乙醇,浓缩至每毫升注射水含生药2g,得到浓缩药液;
5、滴加稀氢氧化钠使上述浓缩药液的pH达到7.0,加该浓缩药液重量0.15%的活性炭煮沸30min,放置12h,过滤,按该浓缩药液重量各加入1%的苯甲醇和吐温-80,搅匀,G-3号垂榕玻璃漏斗过滤,滤液用注射水补足500mL,灌装每瓶10mL,100℃、30min灭菌,即得本治疗猪蓝耳病的中草药注射液。
利用本发明中草药注射液进行的一些试验情况如下:
1、本发明中草药注射液对PRRSV的抑制作用
中药有效成分抗病毒作用的机理,一般认为主要有2条途径,一是直接杀灭病毒,二是抑制病毒的繁殖。本实验按抑制病毒的繁殖途径设计了1组试验,即先接种病毒后加本发明中草药注射液以观察中草药样品能否对细胞内的PRRSV起抑制作用,即抑制其生物合成及成熟释放。本发明中草药注射液对PRRSV的抑制作用测定实验是这样实现的:将100TCID50PRRSV接种至长成单层猴胚胎肾上皮细胞(Marc-145)的96孔细胞培养板上,0.1mL/孔,37℃吸附1.5h,弃去PRRSV液,用磷酸盐缓冲液PBS液洗2次,加入倍比稀释的本发明中草药主要单味中药如青蒿、黄芩、鱼腥草、白花蛇舌草、紫锥菊和本发明中草药注射液,0.1mL/孔,每个稀释度重复4孔,另设细胞对照和PRRSV对照,5%CO2培养箱37℃培养,结果见表1。试验结果表明,本发明中草药注射液主要单味中药如青蒿、黄芩、鱼腥草、白花蛇舌草、紫锥菊对PRRSV在Marc-145细胞上的增殖具有明显的抑制作用,5种单味中药提取物分别在0.25mg/mL、0.25mg/mL、0.25mg/mL、0.125mg/mL浓度时仍具有显著的抑制CPE作用,其中紫锥菊水提物对PRRSV引起的细胞病变CPE最小抑制浓度最低,为0.0625mg/mL;本发明中草药注射液对PRRSV引起的CPE最小抑制浓度也最低,为0.0625mg/mL。
表1本发明中草药注射液对PRRSV在Marc-145细胞上增殖的抑制作用
注:-为正常Marc-145细胞;+为25%的细胞出现细胞病变CPE;++为50%的细胞出现细胞病变CPE;+++为75%的细胞出现细胞病变CPE;++++为100%的细胞出现细胞病变CPE。
2、本发明中草药注射液对猪蓝耳病的治疗效果
2.1分组治疗:取经实验室诊断为猪蓝耳病病猪60头平均分成3组,分别放入3个隔离猪舍内。3个隔离猪舍内猪群分别为本发明中草药注射液组(20头),用本发明中草药注射液注射给药10mL;干扰素组(20头),注射干扰素5mL;抗生素对照组(20头),每头肌肉注射头孢噻肟钠1支;以上各组均每天用药2次,连用5d。另有空白对照组(10头)放在远离病猪群另一猪舍内,不给药。
2.2疗效判定:观察猪的精神、采食、体温、呼吸、皮肤和耳朵颜色及死亡等情况,按如下标准判断疗效。治愈:用药后呼吸平稳,精神、饮食、体温、皮肤和耳朵颜色恢复正常。好转:用药后症状明显减轻,呼吸、精神、体温、饮食好转。无效:用药后症状不减轻,甚至加重或死亡。总有效率=治愈率+好转率。
2.3治疗结果:本发明中草药注射液治愈率和总有效率均显著高于抗生素组和不治疗的空白对照组,但和干扰素组相比差异不显著,表明本发明中草药注射液对猪繁殖与呼吸综合征有疗效,各组的治疗效果见表2。
表2各组的治疗效果(%)
使用本发明中草药注射液治疗猪蓝耳病有较好的疗效,和干扰素相似,高于抗生素对照和空白对照。通过各项试验表明,本发明中草药注射液,对猪蓝耳病有明显的治疗效果。
Claims (2)
1.一种治疗猪蓝耳病的中草药注射液,其特征在于它由下述重量份的原料药制成:青蒿1-2份,黄芩2-4份,鱼腥草4-6份,白花蛇舌草4-6份,紫锥菊4-6份,黄芪4-6份,白术2-4份,甘草1-2份。
2.根据权利要求1所述的治疗猪蓝耳病的中草药注射液,其特征在于它由下述重量份的原料药制成:青蒿2份,黄芩4份,鱼腥草4份,白花蛇舌草4份,紫锥菊4份,黄芪4份,白术2份,甘草1份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200575.2A CN104800370A (zh) | 2015-04-24 | 2015-04-24 | 治疗猪蓝耳病的中草药注射液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510200575.2A CN104800370A (zh) | 2015-04-24 | 2015-04-24 | 治疗猪蓝耳病的中草药注射液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104800370A true CN104800370A (zh) | 2015-07-29 |
Family
ID=53685857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510200575.2A Pending CN104800370A (zh) | 2015-04-24 | 2015-04-24 | 治疗猪蓝耳病的中草药注射液 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104800370A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853943A (zh) * | 2016-06-22 | 2016-08-17 | 蒙焕文 | 一种治疗猪蓝耳病的药物 |
| CN110559287A (zh) * | 2019-09-17 | 2019-12-13 | 香港浸会大学深圳研究院 | 一种用于治疗癌症的药物组合物及其应用 |
| CN116370542A (zh) * | 2023-04-17 | 2023-07-04 | 河南省中兽医药研究院有限公司 | 一种防治猪蓝耳病的中药组合物及其制备方法和应用 |
| CN116966230A (zh) * | 2023-09-11 | 2023-10-31 | 山东利邦牧业股份有限公司 | 一种用于防控猪蓝耳病的发酵中药组合物及其制备方法与应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103142702A (zh) * | 2013-03-21 | 2013-06-12 | 河北科技师范学院 | 治疗猪蓝耳病的中草药注射液及其制备方法 |
-
2015
- 2015-04-24 CN CN201510200575.2A patent/CN104800370A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103142702A (zh) * | 2013-03-21 | 2013-06-12 | 河北科技师范学院 | 治疗猪蓝耳病的中草药注射液及其制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| 冼琼珍等: "10种中药体外抗猪繁殖与呼吸综合征病毒的作用研究", 《黑龙江畜牧兽医》 * |
| 李丹等: "中药体外对猪繁殖与呼吸综合征病毒的影响", 《广东农业科学》 * |
| 李璐璐等: "中药免疫增强剂在动物生产中的应用", 《兽医导刊》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853943A (zh) * | 2016-06-22 | 2016-08-17 | 蒙焕文 | 一种治疗猪蓝耳病的药物 |
| CN110559287A (zh) * | 2019-09-17 | 2019-12-13 | 香港浸会大学深圳研究院 | 一种用于治疗癌症的药物组合物及其应用 |
| CN116370542A (zh) * | 2023-04-17 | 2023-07-04 | 河南省中兽医药研究院有限公司 | 一种防治猪蓝耳病的中药组合物及其制备方法和应用 |
| CN116370542B (zh) * | 2023-04-17 | 2024-05-03 | 河南省中兽医药研究院有限公司 | 一种防治猪蓝耳病的中药组合物及其制备方法和应用 |
| CN116966230A (zh) * | 2023-09-11 | 2023-10-31 | 山东利邦牧业股份有限公司 | 一种用于防控猪蓝耳病的发酵中药组合物及其制备方法与应用 |
| CN116966230B (zh) * | 2023-09-11 | 2024-04-19 | 山东利邦牧业股份有限公司 | 一种用于防控猪蓝耳病的发酵中药组合物及其制备方法与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101658551A (zh) | 一种抗猪病毒病的金银花组合物 | |
| WO2007082416A1 (en) | Traditional chinese medical compositions for treating avian influenza, processes for preparation and usage thereof | |
| CN104367874B (zh) | 一种治疗猪高热病的中药组合物 | |
| CN104258063A (zh) | 提高鸡免疫力的中草药组合物 | |
| CN101156916B (zh) | 一种用于治疗猪高热病的药物 | |
| CN104208393B (zh) | 一种用于防治鸡传染性支气管炎的中药组合物及其制备方法 | |
| CN104800370A (zh) | 治疗猪蓝耳病的中草药注射液 | |
| CN105168807B (zh) | 治疗猪蓝耳病的中药组合物及其制备方法 | |
| CN103181958A (zh) | 治疗奶牛子宫内膜炎的中草药灌注液及其制备方法 | |
| CN104161977B (zh) | 一种用于防治鸡传染性鼻炎的中药组合物及其制备方法 | |
| CN104523952A (zh) | 治疗鸡流感的中草药组合物 | |
| CN104983968B (zh) | 一种退热中药组合物及制备方法 | |
| CN103977372A (zh) | 一种用于治疗猪流行性腹泻的中药添加剂及其制备方法 | |
| CN107737229A (zh) | 防治猪流感的中药饲料添加剂及其制备方法 | |
| CN103494927A (zh) | 一种用于治疗鸡呼吸道疾病的中药组合物及其制备方法 | |
| CN101961468A (zh) | 防治猪呼吸道综合症的中药组合物及其应用 | |
| CN102429961B (zh) | 一种用于治疗感冒的药物组合物胶囊及其制备方法 | |
| CN103142702A (zh) | 治疗猪蓝耳病的中草药注射液及其制备方法 | |
| CN113350429B (zh) | 一种防治非洲猪瘟疾病的中药组合物及其制备方法与应用 | |
| CN111760004B (zh) | 一种防治畜禽流感的中药颗粒及应用 | |
| CN104352880A (zh) | 用于治疗狗细菌感染性感冒的药物组合物及其制备方法 | |
| CN111789913B (zh) | 一种治疗蛋鸡输卵管炎的中药复方制剂及应用 | |
| CN103784600B (zh) | 增强貉子免疫力的中草药口服液 | |
| CN113143991B (zh) | 一种治疗猪瘟的中兽药组合物及其制备方法 | |
| CN111588801A (zh) | 一种预防畜禽疫病的中药分散颗粒剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150729 |